ArticleComputational and structural biotechnology journal2024

The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pancreatic cancer.

Saimeng Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.